LCK Global Kedaton Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? LCK Global Kedaton Tbk. trades at Rp111 (market cap 107B, 39.11M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap, and LCK Global Kedaton Tbk. is more actively traded (39.11M versus 96.7K). Which is the better fit depends on your goals.
| LCKM | OBAT | |
|---|---|---|
Market Cap | 107B | 167.37B |
Volume | 39.11M | 96.7K |
Lot | 391.08K | 967 |
Turnover | 4.36B | 23.82M |
Average Price | 111.56 | 246.34 |
Value | 4.36B | 23.82M |
Indicative Equilibrium Price | 111 | 248 |
Indicative Equilibrium Volume | 3.23K | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT LCK Global Kedaton (the "Company") was established on July 31, 2013 based on Deed of Establishment no. 44 made before Notary Sahat Simanungkalit, SH, M.Kn
Read more on LCKM →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →